3rd Quarter - Report

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -ICD-10 Code for Biomarkers for Alzheimer's Disease -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Anti-obesity medications -Medicaid and the Supplemental Nutrition Assistance Program (SNAP)

LobbyistCovered position, as disclosed
SCOTT FREY New Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

-CDC's ACIP Vaccine Recommendations for Fall 2025 -Marketing practices on telehealth platforms -Impacts of IRA on Older Americans -Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842)

LobbyistCovered position, as disclosed
SCOTT FREY Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER New —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 842 (119th)

Budget/Appropriations BUD

-FY26 report language for the Food and Drug Administration -FY26 report language for the Medicare Program -FY26 report language for the Medicare Prescription Payment Plan -FY26 medical research funding

LobbyistCovered position, as disclosed
SCOTT FREY Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.